Produced to the most demanding industry standards at dedicated facilities, Zephex® propellants are used around the globe.

This commitment to the highest levels of medical propellant quality is supported by a detailed understanding of customer requirements and experienced staff with many years of technical expertise.

Latest News

Koura wins Innovation Award for new ‘green’ medical propellant

Global leader in medical propellants, Koura, has been recognised at the Chemical Northwest Awards for Innovation for its new Zephex® 152a medical propellant.  Koura’s work in innovation is being celebrated for its development of a low-carbon medical propellant, Zephex® 152a. Pressurized metered-dose-inhalers (pMDI) using Zephex® 152a will bring about a greater than 90 percent reduction in the carbon…

Read More
Koura logo

Koura announces major investment into new ‘greener’ medical propellant production facility in United Kingdom

Koura announces a multimillion-pound sterling investment into a new cGMP Zephex® 152a medical propellant production facility at their Runcorn, UK location. This investment is part of a program to bring Zephex® 152a from the laboratory to the patient and will provide a scaling-up in production…

Read More

Koura Donates 10,000 Inhalers to the Government of Maharashtra, India (Haffkine Institute)

Koura, part of Orbia Advance Corporation S.A.B. de C.V. (BMV: ORBIA*), makes a successful donation delivery of 10,000 medical grade inhalers to the Government of Maharashtra, India. The delivery of these inhalers will help Indian authorities maintain critical equipment supplies at a time when need…

Read More